Escolar Documentos
Profissional Documentos
Cultura Documentos
INHERENT RATES
Sinoatrial Node (SA)
60-100
PR INTERVAL
Represents
time from the beginning of atrial depolarization to the beginning of ventricular depolarization Measured from the beginning of the P wave to the beginning of the QRS complex 0.12-0.20
QRS INTERVAL
Represents the length of time for depolarization of the ventricular muscle Measured from the beginning of the QRS complex to the end of the S wave Should measure between 0.06-0.10 seconds in duration
ST INTERVAL
Represents
the total length of time for ventricular muscle to be depolarized and repolarized Measured from the beginning of the QRS complex to the end of the T wave Normal range I s 0.32-0.42
Heart Rate
Calculating the Heart Rate
6 Big
Rhythm Analysis
Five Step Method Determine the Heart Rate Determine the Heart Rhythm Analyze the P Waves Measure the PR Interval Measure the QRS Duration
Rhythm
Node SA Node
Etiology
May be a normal variation in athletes and healthy young adults Excessive vagal stimulation Medical Conditions Anorexia Atherosclerotic heart disease
Hypothermia
Medications Antihypertensives
Symptoms
Symptoms relate to decreased cardiac output Chest pressure and pain Hypotension Dizziness Seizures Syncope Confusion Diaphoresis Ventricular ectopy
Treatment
Interventions
only if
symptomatic
Aimed at
increasing
Digoxin
Sinus Bradycardia
SA Node
below 60 bpm
Regular
Rhythm
Sinus Tachycardia
Node SA Node
Rate
above 100 bpm
Etiology
Diet caffeine Lifestyle Smoking/ nicotine Medical conditions Anemia hemorrhage fever hypotension pain shock Medications Central nervous stimulants Myocardial damage
Medications
Antipyretics and antibiotics for fever and infection Beta Blockers Nitrates or Morphine for Angina
Symptoms
Assessment
Normal response to physical activity Anxiety Fear Fever Anemia Hypoxemia
Hyperthyroidism
Treatment
Interventions
Treat underlying cause Oxygen Rest
Intravascular Volume replacement in Hypovolemia
Atrial Fibrillation
(most common AND in men more than women)
None
Assessment
ECG Intermittent or chronic Symptoms depend on ventricular rate Risk for inadequate cardiac output May have Pulse deficit Fatigue Weakness SOB Dizziness Anxiety Hypotension Risk for systemic emboli
Interventions
Oxygen
Medications
Cardioversion
Radiofrequency
Catheter Ablation
Maze Procedure
Node
Rate
250-350 bpm
Rhythm PR Interval
Etiology
Rheumatic or ischemic heart disease CHF Valvular Disease Pulmonary Emboli
Medications
Digitalis Beta blocker Calcium channel blocker
Symptoms
Assessment
ECG Symptoms depend on ventricular response Palpitations Weakness Fatigue SOB Anxiety Syncope Angina CHF ECG Symptoms depend on the duration and the rate Palpitations Weakness Fatigue SOB Anxiety Hypotension Syncope
Treatment
Interventions
Oxygen
Medications
Paroxysmal
Supraventricular
100- 280
Tachycardia
(Rapid stimulation of atrial tissue)
Assessment
Interventions
If terminated spontaneously, no intervention
Medications
Cardioversion
Atrio-Ventricular Block
First Degree AV Block Second Degree AV Block, Type I Second Degree AV Block, Type II Third Degree AV Block
Medications
Beta blockers Calcium channel blockers Dig toxicity
Usually not treated unless the cause is related to a med that can be modified or withheld
Node
Rate
Rhythm PR Interval
Etiology
Medications
Symptoms
Assessment
ECG Usually
asymptomatic
Treatment
Interve
Wenckebach or Mobitz Type I Sinus impulse takes a little longer to conduct through the impaired AV node until one impulse is completely blocked
ntions
None
Usually transient
pacer
Mobitz Type II Occurs below the Bundle of His Impulses may be blocked randomly, making the ventricular rhythm irregular Could progress to a more serious block
Assessment
Atropine (usually ineffective)
ECG Symptoms depend on number of dropped beats and the overall ventricular rate If Cardiac Output is inadequate, the client may be symptomatic
Complete Heart Block None of the sinus impulses conduct to the ventricles
Assessment
Atropine
ECG Confusion Syncope Stokes-Adams Syndrome CHF Hypotension May lead to cardiac arrest
Interventions
Node
Rate
Rhythm PR Interval
Etiology
Medications
Diltiazem Verapamil Digoxin Propranolol Procainamide Quinidine vasopressor
Symptoms
Assessment
Treatment
Interventions Vagal maneuvers Carotid sinus pressure Medications
Irritable area of tissue in the atria that dominates the SA node and takes over as the pacemaker Usually preceded by premature atrial contractions Begins and ends abruptly The rapid rate prevents adequate ventricular filling
Assessment
May be asymptomatic Palpitations Chest pain Peripheral pulses may be diminished or absent May be a warning sign
Interventions
Medications
Bigeminy unifocal
Bigeminy Multifocal
Trigeminy Quadrigiminy
Rhythm
Ventricular Tachycardia
Node
Rate
Rhythm PR Interval
Etiology
Medications
Symptoms
Assessment
ECG Assess ABCs LOC
Treatment
Interventions
ACLS
Ventricular Fibrillation
Electrical chaos in the ventricles No recognizable deflections Ventricles quiver No cardiac output Fatal
Nonsurgical treatment
Medication Therapy Vagal Maneuvers Temporary Pacing CPR Cardioversion Defibrillation
Surgical Management
PPM CABG Implantable Cardioverter/Difibrillator Open-Chest Cardiac Massage
Assessment
ECG ABCs Interventions ACLS
Nursing Process
Diagnoses Decreased Cardiac Output Anxiety related to fear of the unknown Knowledge deficient about the dysrhythmia and treatment Planning and Goals Eradicating or decreasing the incidence of the dysrhythmia Acquire knowledge about the dysrhythmia and treatment Interventions Monitor BP, Pulse Rate and Rhythm, Respirations, Breath Sounds Episodes of dizziness Rhythm strips Medication Administration Assist in developing a plan to modify lifestyle Minimize anxiety Teach self care Evaluation Expected outcomes Maintain Cardiac Output Expresses decreased anxiety Expresses understanding of dysrhythmia